Multiply Labs partners with AstraZeneca to automate cell therapy manufacturing with robotics

Multiply Labs has actually gotten to an arrangement with pharmaceutical large AstraZeneca to assess the possibility for using GMP (Great Production Practices)- prepared robot systems to commercial-scale cell treatment production. Multiply Labs is an expert in independent production innovation for sophisticated treatments. The partnership will certainly concentrate on end-to-end robot automation of industry-standard tools utilized in cell treatment manufacturing […].

发布者:Sam Francis,转转请注明出处:https://robotalks.cn/multiply-labs-partners-with-astrazeneca-to-automate-cell-therapy-manufacturing-with-robotics/

(0)
上一篇 2 2 月, 2026 10:19 下午
下一篇 2 2 月, 2026 10:19 下午

相关推荐

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

联系我们

400-800-8888

在线咨询: QQ交谈

邮件:admin@example.com

工作时间:周一至周五,9:30-18:30,节假日休息

关注微信
社群的价值在于通过分享与互动,让想法产生更多想法,创新激发更多创新。